Jerry Carter

In response to COVID-19 outbreaks, mRNA vaccine technology has been rapidly developed and successfully applied. the standard method of immunization with the SARS-CoV-2 mRNA vaccine consists of two...

Triumvira Immunologics stated in September that it had completed the first patient dosage in a clinical trial of its TAC-T cell therapy, TAC01-HER2, for the treatment of HER2-positive solid tumors...

As commonly used antibody screening technologies, hybridomas and phage display libraries have their own characteristics.The heavy chain and light chain of hybridoma mAbs derive from a B cell, which is...

COVID-19 caused by SARS-CoV-2 was one of the most important pandemics of this century, and animal models have played a key role in helping to rapidly develop preventive vaccines and therapeutic drugs...

COVID-19, caused by the SARS-CoV-2 virus, is the most severe epidemic of the twentieth century. Since the outbreak in late 2019, animal models have been crucial in assisting in the rapid development...

Phage Display Library ConstructionCreative Biolabs is excited to play a part as an exhibitor at the upcoming 21st BioPharma Drug Discovery Nexus Conference, taking place from October 22 in New Jersey...

Creative Biolabs attended the 21st BioPharma Drug Discovery Nexus Conference as an exhibitor for the first time on October 22–23.SDAB (Single-Domain Antibodies)"This event, a major hub for service...

Creative Biolabs significantly contributes to the advancement of oncolytic virus therapy with full-set services and blue-ribbon products.Oncolytic Virus Immunogenicity StudyResearch is underway in...

Creative Biolabs elaborates on the development mechanisms of DC and mRNA vaccines, two of the most promising cancer vaccine candidates.DC VaccinesThe pursuit of competent cancer vaccines has gained...

Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries.mRNA technology platformmRNA technology platformRecent headlines have been dominated by the...

Creative Biolabs is proud to announce its new-year resolution to dive deeper into sourcing professional animal model solutions for neurological disorder studies. Advanced pharmacokinetics models in...

Recently, scientists at the University of Pittsburgh have deciphered the mechanism by which cancer cells resist chemotherapy and the key protein Xkr8 in it, and have developed an anti-cancer...

CureVac strengthens cancer vaccine research and development through the acquisitionCureVac announced a collaboration with myNEO last month to look for neoantigens on the surface of tumor cells in...

CAR Cell ProductsCreative Biolabs introduces their products for CAR-T therapy R&D as an active response to recent headlines celebrating the success of CAR-T therapies in treating blood cancers, such...

Drug discovery is moving toward increasingly human-relevant experimental systems. Organoids, microphysiological systems, computational modeling, and other new approach methodologies are changing how...